Podcast 1 Mar 2024The final chapter in genomic medicines? Explore the future of genomic medicine with Tome Biosciences’ programmable genomic integration technique, set to revolutionize gene editing. March 1, 2024 Share WhatsApp Twitter Linkedin Email
Podcast 23 Feb 2024Precision neuromedicine: A new dawn for neurological disorders This week on our podcast, explore how precision neuromedicine is reshaping neurological care with Rapport Therapeutics. February 23, 2024 Share WhatsApp Twitter Linkedin Email
Podcast 16 Feb 2024How does AI help drug discovery? Listen to our podcast to discover how AI is revolutionizing drug discovery by tackling “undruggable” cancer targets like KRAS. February 16, 2024 Share WhatsApp Twitter Linkedin Email
Podcast 9 Feb 2024Biosimilars and what’s new in cell and gene therapies This week on the podcast, we have a conversation with Fran Gregory, vice president of Emerging Therapies at Cardinal Health. The discussion covers the company’s role in healthcare, biosimilars, the latest in cell and gene therapies, and Advanced Therapies Week. About Cardinal Health Cardinal Health is a distributor of pharmaceuticals and a global manufacturer and […] February 9, 2024 Share WhatsApp Twitter Linkedin Email
Podcast 2 Feb 2024BioSenic showcasing knee osteoarthritis treatment Explore a groundbreaking approach to knee osteoarthritis treatment with BioSenic’s JTA-004. Listen to our podcast to learn more! February 2, 2024 Share WhatsApp Twitter Linkedin Email
Podcast 26 Jan 2024Transforming the vaginal microbiome to combat infertility Freya Biosciences is a clinical-stage biotech company with headquarters in Copenhagen, Denmark, and Boston, Massachusetts. It is dedicated to reimagining women’s health and redefining fertility for those previously deprived of options. With a focus on microbial immunotherapies, Freya addresses immune drivers underlying a range of reproductive health conditions. The company recently received $38 million Series […] January 26, 2024 Share WhatsApp Twitter Linkedin Email
Podcast 19 Jan 2024Epigenetic editing – the power of CRISPR without cutting DNA Epic Bio is an epigenetic editing company, leveraging the power of CRISPR without cutting DNA. The company’s proprietary Gene Expression Modulation System (GEMS) includes the smallest Cas protein known to work in human cells. This enables in vivo or ex vivo delivery via a single viral vector. Epic’s lead program, EPI-321, is in IND-enabling studies […] January 19, 2024 Share WhatsApp Twitter Linkedin Email
Podcast 12 Jan 2024Could natural killer cells transform Alzheimer’s treatment? Join Dr. Paul Song, CEO of NKGen Biotech, in a podcast exploring the revolutionary use of NK cells for Alzheimer’s treatment. January 12, 2024 Share WhatsApp Twitter Linkedin Email
Podcast 5 Jan 2024Gene editing in the microbiome could provide acne solution Explore Eligo Bioscience’s groundbreaking CRISPR-based approach, modifying the microbiome to combat moderate to severe acne. January 5, 2024 Share WhatsApp Twitter Linkedin Email
Podcast 15 Dec 2023Vaxxinity making vaccines to change the world Discover how Vaxxinity’s vaccine approach aims to democratize global health, potentially reshaping access to innovative treatments worldwide. December 15, 2023 Share WhatsApp Twitter Linkedin Email
Podcast 8 Dec 2023Can worms provide treatments for some diseases? U.S. company Holoclara is looking to tackle diseases through the development of worm-derived therapeutics. Allergic and autoimmune diseases were first described in the early 1900s, which Holoclara said is the same time that gut-resident worms such as the roundworm, Caenorhabditis elegans, were removed from people in industrialized countries. The company, led by CEO Andrea Choe, […] December 8, 2023 Share WhatsApp Twitter Linkedin Email
Podcast 1 Dec 2023Ipsen drug gives hope for liver disease patients On the podcast this week, we are looking at recent advances in treating certain liver diseases. Jennifer Schranz is senior vice president and global head of rare diseases in the R&D division at Ipsen, and she discusses a breakthrough treatment for primary biliary cholangitis and cholestatic liver disease. What is primary biliary cholangitis? Primary biliary […] December 1, 2023 Share WhatsApp Twitter Linkedin Email